PRPH ProPhase Labs
- 5.240
- +0.210+4.17%
- 5.100
- -0.140-2.67%
ProPhase Labs News
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Call Transcript
ProPhase Labs | 10-Q: Quarterly report
Correction to ProPhase Labs 1Q Loss Per Share Headline on May 9
ProPhase Labs reported a first-quarter loss of 35 cents a share. "ProPhase Labs 1Q Loss/Shr 7c >PRPH," at 8 a.m. ET on May 9, misstated the number in the headline.
Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, Vs. Street Est of $9.9M
03:56 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M
ProPhase Labs 1Q Loss/Shr 35c >PRPH
ProPhase Labs 1Q Loss/Shr 35c >PRPH
Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M
08:03 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M
ProPhase Labs Q1 2024 GAAP EPS $(0.07) Beats $(0.18) Estimate, Sales $3.634M Miss $9.860M Estimate
ProPhase Labs (NASDAQ:PRPH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.18) by 61.11 percent. The company reported quarterly sales of $3.634 millio
ProPhase Labs 1Q Loss/Shr 7c >PRPH
ProPhase Labs 1Q Loss/Shr 7c >PRPH
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call ho
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroC
ProPhase Labs Shares Jump on New AI-Based Project
By Dean Seal Shares of ProPhase Labs jumped after the biopharma and diagnostics company unveiled a new project that utilizes an artificial-intelligence platform and its massive genomics database. Th
ProPhase Labs Unveils Project ZenQ-AI; Leveraging ProPhase Labs' AI Platform, Massive Genomics Database And Patented Esophageal Cancer Insights For Antibody Drug Conjugates Development
Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development.Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) -- Pr
ProPhase Labs Unveils Project ZenQ-AI
Leveraging ProPhase Labs' AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE) --
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management With Launch of Its BE-Smart Test in H2 2024
Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and diagnostics company, today reported its progress on the
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase" or the "Company"), a next-generation biopharma, genomics, and diagnostics company, today announced that it has granted
Earnings Call Summary | ProPhase Labs(PRPH.US) Q4 2023 Earnings Conference
The following is a summary of the ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript:Financial Performance:ProPhase Labs increased profitability in the Pharmaloz sector due to boosted global
ProPhase Labs 2023 Loss/Shr $0.98 >PRPH
ProPhase Labs 2023 Loss/Shr $0.98 >PRPH
ProPhase Labs GAAP EPS of -$0.98 Misses by $0.24, Revenue of $45.2M Misses by $6.38M
ProPhase Labs 2023 Rev $45.2M >PRPH
ProPhase Labs 2023 Rev $45.2M >PRPH
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant...
Analysis
Price Target
No Data
